Lyell Immunopharma (NASDAQ:LYEL) Receives Nasdaq Notification Regarding Minimum Bid Price Requirements
Lyell Immunopharma, Inc. (NASDAQ: LYEL) recently disclosed in a Form 8-K filing with the Securities and Exchange Commission that it has received a notice from the Listing Qualifications Staff of The Nasdaq Stock Market LLC. The notice, received on January 23, 2025, informed the company that for the past 33 consecutive business days, the bid […]
More Stories
High Gas Prices Could Be the Key Issue That Swings the Senate
By Jeremy Lott Enough voters are fixated on the price of fuel that it could be the deciding issue in...
Treasury Sanctions Iraqi Bank and Iranian Shadow Networks
By Kimberly Hayek The Treasury Department has sanctioned the Iraq-based International Development Bank for Investment and Finance (IDB) and related...
Trump Seeks to Boost Georgia Voters at Rally With Early Voting Underway
By Troy Mters DALTON, Ga.—President Donald Trump, aboard Marine One, flew directly over hundreds of supporters gathered for his rally...
16 Foreign Nationals Charged for Illegal Voting, DOJ Says
By Kimberly Hayek Sixteen foreign nationals in North Carolina, New York, and Idaho, including an illegal immigrant, have been charged...
Renewal Status for Marshals Season 3! Plot, Release Date, and Cast
Luke Grimes is back as everyone’s favourite marshal, Kayce Dutton. The second season of the series is streaming globally, and...
Katie Zacharia Out as Press Secretary, White House Confirms
By Jack Phillips A White House official on Friday told The Epoch Times that new White House press secretary Katie...
